Viromed Medical AGXTER:VME -1.39%22 Quick Ratio is 2.39 as of Dec. 2025, which is 35% above its 10-year median of 1.77. GuruFocus rates XTER:VME with a GF Score™ of 22/100. The stock has 5 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Viromed Medical AG ranks better than 60.47% on this metric.
Viromed Medical AG has a quick ratio of 2.39. It generally indicates good short-term financial strength.
The historical rank and industry rank for Viromed Medical AG's Quick Ratio or its related term are showing as below:
XTER:VME'
s Quick Ratio Range Over the Past 10 Years
Min: 1.08 Med: 1.77 Max: 3.14
Current: 2.39
During the past 5 years, Viromed Medical AG's highest Quick Ratio was 3.14. The lowest was 1.08. And the median was 1.77.
XTER:VME's Quick Ratio is ranked better than 60.47% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 1.86
vs XTER:VME: 2.39
Viromed Medical AG (XTER:VME) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Viromed Medical AG Quick Ratio Related Terms
Viromed Medical AG Quick Ratio Historical Data
* Premium members only.
The historical data trend for Viromed Medical AG's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Viromed Medical AG's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viromed Medical AG Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viromed Medical AG's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Viromed Medical AG's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Viromed Medical AG's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viromed Medical AG (XTER:VME) has a Quick Ratio of 2.39 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Viromed Medical AG and its competitors. This is 35% above median its historical median of 1.77. Over the past decade, Viromed Medical AG's Quick Ratio has ranged from 1.08 to 3.14. According to the industry distribution chart, Viromed Medical AG ranks #338 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 39.5%.
Is Viromed Medical AG's Quick Ratio too high?
Viromed Medical AG's current Quick Ratio of 2.39 is 35% above median its 10-year median of 1.77. Over the past 10 years, this metric has ranged from a low of 1.08 to a high of 3.14. The Medical Devices & Instruments industry median Quick Ratio is 1.86. Viromed Medical AG's value of 2.39 is 28.5% above this industry median. Based on the distribution chart, Viromed Medical AG ranks #338 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Viromed Medical AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Viromed Medical AG ranks #338 out of 855 companies for Quick Ratio. This puts Viromed Medical AG in the upper half of its industry. The industry median Quick Ratio is 1.86. Viromed Medical AG's value of 2.39 is 28.5% above this benchmark. Historically, Viromed Medical AG's own Quick Ratio has ranged from 1.08 to 3.14 over the past decade. While the company's 10-year median is 1.77 vs. the industry median of 1.86, Viromed Medical AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.86, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viromed Medical AG's current Quick Ratio of 2.39 is 28.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Viromed Medical AG and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viromed Medical AG's current Quick Ratio is 2.39, which is 35% above median its own 10-year median of 1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (XTER:VME) has a current Quick Ratio of 2.39. The current Quick Ratio is 2.39, which is 35% above median its 10-year median of 1.77 and 28.5% above the Medical Devices & Instruments industry median of 1.86. Viromed Medical AG's overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Viromed Medical AG (XTER:VME), the current Quick Ratio is 2.39 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
22GF Score
Get the complete analysis for XTER:VME
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:VME has been successfully added to your 
